The Human Male Mammary Gland has Similar Epithelial Populations to Female but Distinct Composition and Transcriptional Properties

This study presents the first single-cell RNA sequencing atlas of the normal adult human male breast, revealing that while it retains the same three epithelial populations as the female breast, it exhibits a distinct composition with an abundance of luminal committed cells and unique transcriptional properties characterized by elevated estrogen receptor activity, which provides a critical reference for understanding male breast cancer biology.

The Gist

The Big Picture: The "Forgotten" Breast

For a long time, scientists have studied the female breast in incredible detail, mapping out every type of cell like a city planner drawing a map of a bustling metropolis. They know exactly which cells build the roads (ducts), which ones make the milk (lobules), and how they talk to each other.

But the male breast? It's been like a ghost town on that map. We knew it existed, and we knew men could get breast cancer, but we didn't know what the "normal" neighborhood looked like before the cancer showed up. This paper is the first time scientists have put on high-powered glasses (single-cell sequencing) to look at the normal male breast and say, "Okay, here is exactly what is happening here."

The Main Discovery: A Different Kind of City

The researchers found that the male breast isn't just a "shrunken" version of the female breast. It's a completely different architectural style.

The Analogy: The Construction Crew
Imagine the female breast is a construction site with three types of workers:

1. The Bosses (Basal Cells): They hold the structure together.
2. The Apprentices (Luminal Progenitors): Young workers learning the trade, ready to become anything.
3. The Master Craftsmen (Luminal Committed): The finished, specialized workers who do the specific job.

In a female breast, you have a healthy mix of all three. It's a balanced workforce.

In a male breast, the researchers found something surprising:

• The Bosses and Apprentices are almost gone.
• The city is almost entirely made up of Master Craftsmen.

The male breast is dominated by one specific type of cell (the "Luminal Committed" cell). It's like walking into a factory where 90% of the workers are senior engineers, and there are barely any managers or trainees left.

The "Super-Prepared" Worker

The most interesting part is how these male Master Craftsmen behave.

The Analogy: The Library vs. The Factory

• Female cells are like a busy factory floor. They are constantly receiving orders, reacting to signals, and building things. They are very responsive to the environment.
• Male cells are like a library that is perfectly organized but quiet. They have all the books (RNA) ready to be read, and their printing presses (ribosomes) are polished and ready to go, but they aren't currently printing a lot of new books.

The study found that male cells are "translationally poised." This means they are sitting there, fully loaded with the tools to make proteins, but they are in a state of "low power mode." They aren't dividing or growing as fast as female cells. They are waiting.

The Hormone Connection: Why Men Get Breast Cancer

This is the "Aha!" moment of the paper.

We know that Male Breast Cancer is almost always driven by Estrogen (the "female" hormone), whereas Female Breast Cancer can be driven by many different things.

The study found that these "Master Craftsmen" in men are super-sensitive to Estrogen.

• They have a lot of "antennas" (receptors) tuned to pick up estrogen signals.
• They even have their own little internal factories that can turn weak hormones into strong estrogen right inside the cell.

The Metaphor:
Imagine the male breast cells are like a radio tuned specifically to the "Estrogen" frequency. Even if the signal from the outside world is weak, the radio is so sensitive and has its own amplifier that it turns the volume up to 10.

This explains why male breast cancer is almost always "ER-positive" (Estrogen Receptor positive). The normal cells are already set up to listen to estrogen, so when cancer starts, it's almost always hijacking that same channel.

The "Time Capsule" Theory

The researchers also noticed that these male cells seem to hold onto some "childhood memories."

The Analogy:
Female breasts go through a massive remodeling process after puberty (growing lobules for milk). Male breasts don't really do this; they stay in a simpler, duct-only state.
The study found that the male cells still have active "blueprints" for early development (genes like HOX and TBX3). It's as if the male breast cells are stuck in a "time capsule" of early development, never fully moving on to the next stage of adulthood that female cells go through.

Why Does This Matter?

1. Better Treatment: Now that we know the "normal" male breast looks like this, we can compare cancer cells to it. We can see exactly what went wrong.
2. Understanding Risk: It helps explain why men get a specific type of cancer that is very sensitive to hormones.
3. The "Ghost Town" Problem: The study also highlighted a practical problem: It is very hard to get enough cells from men to study. The male breast is so sparse that it's like trying to study a forest by collecting leaves, but the trees are so far apart you can't find enough leaves. This explains why we haven't had this data before.

The Bottom Line

This paper is the first "User Manual" for the normal male breast. It tells us that the male breast is a quiet, estrogen-sensitive, developmentally "frozen" system dominated by one specific type of cell. Understanding this baseline is the key to unlocking why male breast cancer happens and how to treat it better.

Technical Summary

1. Problem Statement

Despite the clinical significance of Male Breast Cancer (MBC), which is characterized by near-universal Estrogen Receptor (ER) positivity (>90%) and distinct genetic susceptibility compared to female breast cancer, the normal adult male breast has never been characterized at single-cell resolution.

• Knowledge Gap: While the cellular hierarchy of the female breast (Basal, Luminal Progenitor, and Luminal Committed cells) is well-defined, the cellular composition, abundance, and transcriptional state of the normal male mammary epithelium remain undefined.
• Clinical Consequence: Without a normal tissue reference, it is impossible to accurately interpret tumor-associated transcriptional changes, model the cellular origins of MBC, or contextualize germline susceptibility variants specific to men.
• Biological Context: Male breast tissue is a rudimentary ductal system lacking terminal duct lobular units (TDLUs), yet it retains hormone-responsive capacity (evidenced by gynecomastia and induced lactation). The specific nature of this retained epithelium is unknown.

2. Methodology

The study employed an integrated multi-omics approach combining flow cytometry, in vitro culture assays, and single-cell RNA sequencing (scRNA-seq).

• Cohort:
  • Male: 8 adult donors (mean age 60.5) for phenotypic analysis; 3 donors (mean age 66) provided sufficient cells for scRNA-seq.
  • Female: 27 adult donors (mean age 47.2) for phenotypic analysis; 3 in-house + 11 public donors (Nee et al.) for scRNA-seq integration.
• Sample Processing:
  • Tissue was dissociated into organoids and single cells.
  • FACS Sorting: Cells were sorted based on lineage depletion (CD31⁻, CD34⁻, CD45⁻) and surface markers (EpCAM and CD49f) to define Luminal-like, Luminal Progenitor-like, Basal-like, and Stromal-like fractions.
  • Culture Assays: Sorted cells were tested for 2D proliferation (doubling times) and 3D organoid formation capabilities.
• Single-Cell Sequencing & Analysis:
  • Library Prep: 10x Genomics Chromium Next GEM v3.1.
  • Integration: scRNA-seq data from 3 male and 14 female donors were integrated (Total: 174,471 cells).
  • Computational Pipeline:
    • Preprocessing: Quality control, doublet removal (DoubletFinder), and imputation (ALRA).
    • Batch Correction: SCALEX algorithm to integrate datasets and remove batch effects.
    • Clustering: Louvain algorithm on a shared nearest-neighbor graph.
    • Differential Expression: Pseudobulk approach (summing counts per donor) using edgeR and limma-voom to avoid skewing from variable cell numbers.
    • Functional Analysis: Gene Ontology (GO), Ligand-Receptor profiling (NicheNet), and Transcription Factor (TF) activity inference (decoupleR/CollecTRI).

3. Key Results

A. Epithelial Scarcity and Variability

• Low Yield: Male breast tissue yields significantly fewer epithelial cells (0–15% EpCAM⁺) compared to females (20–70%).
• Phenotypic Instability: FACS profiles in males are highly variable and often fail to resolve the three distinct female fractions (Basal, LP, LC). The "Basal-like" gate in males is frequently contaminated by stromal pericytes (RGS5⁺) rather than true basal epithelial cells (KRT5/14⁺).
• Culture Kinetics: Male-derived cells proliferate slower (longer doubling times) and take longer to form 3D organoids (~3 weeks vs. <1 week for females) but remain viable for extended periods (>6 weeks).

B. Distinct Cellular Composition (LC-Dominance)

• Compositional Shift: scRNA-seq revealed that the male breast epithelium is dominated by Luminal Committed (LC) cells.
  • LC Proportion: Significantly higher in males (p<0.01).
  • Basal (BC) Proportion: Significantly lower in males (p<0.05).
  • LP Proportion: No significant difference, though the overall architecture is shifted toward the LC vertex in ternary space.
• Implication: The male breast lacks the basal and progenitor diversity seen in females, consisting primarily of a differentiated, hormone-sensing LC population.

C. Transcriptional Signatures of Male LC Cells

Male LC cells exhibit a unique transcriptional state distinct from female LC cells:

1. Elevated Hormone Receptors: Significantly higher mRNA expression of ESR1 (ERα) and PGR (Progesterone Receptor). This aligns with the clinical ER⁺ status of MBC.
2. Metabolic & Biosynthetic State: Enrichment of RNA processing, ribosome biogenesis, and rRNA/tRNA metabolic processes. This suggests a "translationally poised" state rather than quiescence.
3. Suppressed Signaling: Reduced expression of inflammatory cytokines, growth factors, and immune response genes. Upregulation of cytokine suppressors (SOCS2, SOCS4) suggests an intrinsic dampening of signaling pathways.
4. Developmental Patterning: Elevated inferred activity of developmental transcription factors (e.g., HOX family, MEIS1, MSX2, TBX3, ELF5) and chromatin regulators (SMARCA5, CTCFL). This suggests male LC cells retain aspects of an earlier developmental state with limited postnatal remodeling.
5. Local Estrogen Synthesis: Enrichment of enzymes HSD17B1 and HSD17B12 (converting estrone to estradiol) in male LC, suggesting potential autocrine estradiol production to sustain ER signaling.

D. Correlation with Breast Cancer Subtypes

• Male LC Signature: Strongly correlates with Luminal A and Normal-like breast cancers; negatively correlates with Basal-like and Luminal B.
• Male LP Signature: Correlates with Basal-like tumors.
• Conclusion: The cell-of-origin relationships observed in females (LP $\to$ Basal-like; LC $\to$ Luminal) are conserved in males, despite the compositional shift.

4. Key Contributions

1. First Single-Cell Atlas of the Normal Male Breast: Provides the first high-resolution reference map of the adult human male mammary gland, defining its cellular architecture and transcriptional landscape.
2. Resolution of Phenotypic Discrepancies: Demonstrates that standard FACS phenotyping (EpCAM/CD49f) is unreliable for male tissue due to stromal contamination and variable gating, establishing scRNA-seq as the necessary gold standard for classification.
3. Molecular Basis for MBC: Identifies Luminal Committed (LC) cells as the most biologically plausible cell-of-origin for Male Breast Cancer, supported by their numerical dominance, elevated ER/PGR expression, and transcriptional similarity to Luminal A tumors.
4. Resource for Future Research: Establishes a dataset for investigating sex differences in mammary biology, interpreting germline susceptibility variants, and modeling breast malignancies in a sex-specific context.

5. Significance and Clinical Implications

• Understanding MBC: The study explains the near-universal ER positivity of MBC by showing that the normal male epithelium is inherently enriched for ER-high LC cells.
• Therapeutic Insights: The suppression of inflammatory signaling and the reliance on local estrogen synthesis (via HSD17B1/12) in male tissue may offer new targets for therapy or explain resistance patterns.
• Developmental Biology: The retention of developmental patterning factors (HOX, TBX3) in adult male LC suggests that the male breast is not merely a "regressed" female breast but a distinct tissue state with a unique transcriptional identity established during development.
• Limitations & Future Directions: The study notes a confounding age difference between male (mean 66) and female (mean 41) scRNA-seq cohorts. Future work requires age-matched donors and direct comparison with MBC tumor datasets to confirm the cell-of-origin hypothesis.

In summary, this paper fundamentally shifts the understanding of male breast biology from a "rudimentary" system to a distinct, LC-dominant tissue with a unique transcriptional program that predisposes it to ER-positive malignancies.